Logo do repositório
 
Publicação

Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Report

dc.contributor.authorTavares, I.
dc.contributor.authorLobato, L.
dc.contributor.authorMatos, C.
dc.contributor.authorSantos, J.
dc.contributor.authorMoreira, P.
dc.contributor.authorSaraiva, M.
dc.contributor.authorCastro Henriques, A.
dc.date.accessioned2016-08-01T10:26:41Z
dc.date.available2016-08-01T10:26:41Z
dc.date.issued2015
dc.description.abstractSystemic hereditary amyloidoses are autosomal dominant diseases associated with mutations in genes encoding ten different proteins. The clinical phenotype has implications on therapeutic approach, but it is commonly variable and largely dependent on the type of mutation. Except for rare cases involving gelsolin or transthyretin, patients are heterozygous for the amyloidogenic variants. Here we describe the first patient identified worldwide as homozygous for a nephropathic amyloidosis, involving the fibrinogen variant associated with the fibrinogen alpha-chain E526V (p.Glu545Val) mutation. In 1989, a 44-year-old woman presented with hypertension, hepatosplenomegaly, nephrotic syndrome, and renal failure. She started hemodialysis in 1990 and 6 years later underwent isolated kidney transplantation from a deceased donor. Graft function and clinical status were unremarkable for 16 years, despite progressively increased left ventricular mass on echocardiography. In 2012, 4 months before death, she deteriorated rapidly with severe heart failure, precipitated by Clostridium difficile colitis and urosepsis. Affected family members developed nephropathy, on average, nearly three decades later, which may be explained by the gene dosage effects on the phenotype of E526V (p.Glu545Val) fibrinogen A alpha-chain amyloidosis.pt_PT
dc.identifier.citationCase Rep Nephrol. 2015;2015:919763pt_PT
dc.identifier.doi10.1155/2015/919763pt_PT
dc.identifier.issn2090-6641
dc.identifier.urihttp://hdl.handle.net/10400.16/1986
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherHindawi Publishing Corporationpt_PT
dc.relation.publisherversionhttp://www.hindawi.com/journals/crin/2015/919763/pt_PT
dc.titleHomozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Reportpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardNumberPEst-OE/SAU/UI0215/2014
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876/PEst-OE%2FSAU%2FUI0215%2F2014/PT
oaire.citation.conferencePlaceUnited States of Americapt_PT
oaire.citation.startPage919763pt_PT
oaire.citation.titleCase Reports in Nephrologypt_PT
oaire.citation.volume2015pt_PT
oaire.fundingStream5876
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublication70596e95-5778-42bc-9d0b-6773613e8f44
relation.isProjectOfPublication.latestForDiscovery70596e95-5778-42bc-9d0b-6773613e8f44

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Homozygosity for the E526V Mutation.pdf
Tamanho:
1.45 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.35 KB
Formato:
Item-specific license agreed upon to submission
Descrição: